Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

TCON / TRACON Pharmaceuticals, Inc. 8-K (Current Report)

2018-02-21 sec.gov
tcon-8k_20180221.htm     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported):  February 16, 2018   TRACON Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter)       Delaware 001-36818 34-2037594 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No. (14-0)

TCON / TRACON Pharmaceuticals, Inc. / 683 Capital Management, LLC - FEBRUARY 14, 2018 (Passive Investment)

2018-02-14 sec.gov
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. 1)* Tracon Pharmaceuticals, Inc. (Name of Issuer) Common stock, $0.001 par value (Title of Class of Securities) 89237H100 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua

TCON / TRACON Pharmaceuticals, Inc. / 683 Capital Management, LLC - FEBRUARY 14, 2018 (Passive Investment)

2018-02-14 sec.gov
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. 1)* Tracon Pharmaceuticals, Inc. (Name of Issuer) Common stock, $0.001 par value (Title of Class of Securities) 89237H100 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua

ROTY Edition 1 Volume 79: Limited Downside Catalysts Vs. Binary Risk

2018-02-14 seekingalpha
We discuss the difference between binary catalysts and those with limited downside, utilizing two recent examples. (166-3)

TCON / TRACON Pharmaceuticals, Inc. / LYTTON LAURENCE W - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment 2) (Name of Issuer) TRACON Pharmaceuticals, Inc. (Title of Class of Securities) Common Stock (CUSIP Number) 89237H100 (Date of Event Which Requires Filing of this Statement) December 31, 2017 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ]Rule 13d-1(b) [ X ]Rule 13d-1(c) [ ]Rule 13d-1(d) CUSIP No.

TCON / TRACON Pharmaceuticals, Inc. / LYTTON LAURENCE W - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment 2) (Name of Issuer) TRACON Pharmaceuticals, Inc. (Title of Class of Securities) Common Stock (CUSIP Number) 89237H100 (Date of Event Which Requires Filing of this Statement) December 31, 2017 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ]Rule 13d-1(b) [ X ]Rule 13d-1(c) [ ]Rule 13d-1(d) CUSIP No.

ROTY Edition 1 Volume 78: Simplify Your Decision-Making And Stick To Guidelines

2018-02-13 seekingalpha
As always, readers are encouraged to do their own due diligence, manage risk appropriately, and avoid blindly following. (313-2)

TCON / TRACON Pharmaceuticals, Inc. / JAFCO Super V3 Investment Limited Partnership - SCHEDULE 13G/A AMENDMENT 2 (Passive Investment)

2018-02-13 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G (Rule 13d-102)   Information to be Included in Statements filed Pursuant to Rule 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 2)*   TRACON PHARMACEUTICALS, INC. (Name of Issuer)   Common Stock (Title of Class of Securities)   H89237H100 (CUSIP Number)   December 31, 2017 (Date of Event Which Requires Filing of this Statement)

TCON / TRACON Pharmaceuticals, Inc. / JAFCO Super V3 Investment Limited Partnership - SCHEDULE 13G/A AMENDMENT 2 (Passive Investment)

2018-02-13 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G (Rule 13d-102)   Information to be Included in Statements filed Pursuant to Rule 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 2)*   TRACON PHARMACEUTICALS, INC. (Name of Issuer)   Common Stock (Title of Class of Securities)   H89237H100 (CUSIP Number)   December 31, 2017 (Date of Event Which Requires Filing of this Statement)

TCON / TRACON Pharmaceuticals, Inc. / EVENTIDE ASSET MANAGEMENT, LLC - SC 13G/A (Passive Investment)

2018-02-12 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* TRACON Pharmaceuticals, Inc. (Name of Issuer) Common stock, $0.001 par value (Title of Class of Securities) 89237H100 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: þ  Rule 13d-1(b) ◻  Rule 13d-1(c) ◻  Rule 13d-1(d) * The

TCON / TRACON Pharmaceuticals, Inc. / EVENTIDE ASSET MANAGEMENT, LLC - SC 13G/A (Passive Investment)

2018-02-12 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* TRACON Pharmaceuticals, Inc. (Name of Issuer) Common stock, $0.001 par value (Title of Class of Securities) 89237H100 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: þ  Rule 13d-1(b) ◻  Rule 13d-1(c) ◻  Rule 13d-1(d) * The

ROTY Edition 1 Volume 77: Market Turmoil Continues - How To React

2018-02-09 seekingalpha
Recent market volatility is addressed and we discuss in depth how to react while sticking to one´s plan. (192-1)

ROTY Edition 1 Volume 76: How To Deal With Market Selloffs And Spring Cleaning For The Contenders List

2018-02-06 seekingalpha
Readers are encouraged to make their voices heard in my recent blog post if they haven´t already. (647-3)

TCON / TRACON Pharmaceuticals, Inc. / FRANKLIN RESOURCES INC - 3G/A (Passive Investment)

2018-02-05 sec.gov
trac17a1.htm - Generated by SEC Publisher for SEC Filing               CUSIP NO. 89237H100                    13G                               Page 1 of 12                                                                                        UNITED STATES                                                               SECURITIES AND EXCHANGE COMMISSION                                                                           Washington, D.

TCON / TRACON Pharmaceuticals, Inc. / FRANKLIN RESOURCES INC - 3G/A (Passive Investment)

2018-02-05 sec.gov
trac17a1.htm - Generated by SEC Publisher for SEC Filing               CUSIP NO. 89237H100                    13G                               Page 1 of 12                                                                                        UNITED STATES                                                               SECURITIES AND EXCHANGE COMMISSION                                                                           Washington, D.


CUSIP: 89237H100